Estados financieros detallados de ALX Oncology Holdings Inc. (ALXO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.76, ALXO presenta beneficios negativos (P/E no significativo) y un ROE del -391.42%. La capitalización bursátil es de $237M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $2.1M | $4.8M | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1.9M | $4.4M | $1.1M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $187000 | $436000 | $107000 | 0 | 0 | 0 | 0 | 0 |
| I+D | $11.3M | $16.3M | $29.0M | $60.2M | $98.4M | $141.8M | $116.4M | $77.0M |
| Generales y Administrativos | $2.6M | $3.3M | $14.8M | $23.4M | $29.0M | $28.5M | $26.1M | $23.9M |
| Gastos Operativos | $13.9M | $19.6M | $43.8M | $83.6M | $127.4M | $170.3M | $142.5M | $104.0M |
| Beneficio Operativo | -$13.7M | -$19.2M | -$43.7M | -$83.6M | -$127.4M | -$170.3M | -$142.5M | -$104.0M |
| EBITDA | -$13.3M | -$18.8M | -$43.5M | -$83.4M | -$122.8M | -$158.4M | -$132.2M | -$99.4M |
| Gastos por Intereses | 0 | $21000 | $811000 | $13000 | $238000 | $1.6M | $1.7M | $1.6M |
| Beneficio Antes de Impuestos | -$13.7M | -$19.2M | -$45.5M | -$83.5M | -$123.4M | -$160.8M | -$134.8M | -$101.7M |
| Impuestos | $45000 | $34000 | $241000 | -$21000 | $64000 | 0 | 0 | 0 |
| Beneficio Neto | -$13.7M | -$19.2M | -$45.7M | -$83.5M | -$123.5M | -$160.8M | -$134.8M | -$101.7M |
| BPA | $-0.79 | $-0.88 | $-1.28 | $-2.07 | $-3.03 | $-3.74 | $-2.58 | $-1.90 |
| BPA Diluido | $-0.79 | $-0.88 | $-1.28 | $-2.07 | $-3.03 | $-3.74 | $-2.58 | $-1.90 |
| Acciones en Circulación (Diluidas) | $22.0M | $22.0M | $39.8M | $40.3M | $40.7M | $43.0M | $52.2M | $53.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$150000 | 0 |
| Beneficio Operativo | -$22.5M | -$23.0M | -$19.0M | -$18.0M |
| EBITDA | -$21.6M | -$22.3M | -$17.4M | -$17.6M |
| Beneficio Neto | -$22.1M | -$22.8M | -$17.9M | -$18.0M |
| BPA | $-0.41 | $-0.42 | $-0.17 | $-0.13 |
| BPA Diluido | $-0.41 | $-0.42 | $-0.17 | $-0.13 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $8.3M | $9.0M | $434.2M | $363.7M | $48.8M | $22.4M | $17.6M | $16.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $217.4M | $160.3M | $110.2M | $28.4M |
| Cuentas por Cobrar | $932000 | $536000 | 0 | 0 | 0 | 0 | $892000 | $298000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $10.2M | $9.8M | $436.0M | $367.0M | $271.0M | $188.7M | $134.4M | $50.7M |
| Inmovilizado Material | $956000 | $860000 | $52000 | $3.5M | $9.8M | $10.8M | $9.6M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $11.2M | $10.7M | $436.1M | $380.2M | $306.5M | $242.6M | $147.8M | $59.0M |
| Cuentas por Pagar | $697000 | $3.7M | $4000 | $3.8M | $8.1M | $8.6M | $4.5M | $4.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $435000 | $5.2M |
| Pasivos Corrientes | $1.9M | $5.0M | $6.2M | $15.3M | $28.3M | $36.0M | $18.5M | $24.6M |
| Deuda a Largo | 0 | $5.4M | 0 | 0 | $9.4M | $9.6M | $9.5M | 0 |
| Pasivos Totales | $2.0M | $11.0M | $6.2M | $17.1M | $43.0M | $52.8M | $34.2M | $33.1M |
| Reservas | -$53.5M | -$72.8M | -$118.5M | -$202.0M | -$325.5M | -$486.3M | -$621.1M | -$722.8M |
| Patrimonio Neto | $9.2M | -$276000 | $429.8M | $363.0M | $263.5M | $189.7M | $113.6M | $26.0M |
| Deuda Total | 0 | $5.4M | 0 | $742000 | $10.4M | $17.2M | $17.0M | $5.2M |
| Deuda Neta | -$8.3M | -$3.6M | -$434.2M | -$362.9M | -$255.8M | -$165.5M | -$110.8M | -$39.6M |
| Capital Circulante | $8.3M | $4.8M | $429.8M | $351.7M | $242.6M | $152.7M | $115.9M | $26.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $23.4M | $16.4M | $32.3M | $22.7M |
| Activos Totales | $82.7M | $59.0M | $178.3M | $160.8M |
| Pasivos Totales | $37.9M | $33.1M | $27.0M | $24.6M |
| Patrimonio Neto | $44.8M | $26.0M | $151.3M | $136.2M |
| Deuda Total | $4.3M | $5.2M | $5.2M | $9.7M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$13.7M | -$19.2M | -$45.7M | -$83.5M | -$123.5M | -$160.8M | -$134.8M | -$101.7M |
| Amortizaciones | $431000 | $429000 | $202000 | $51000 | $342000 | $836000 | $872000 | $706000 |
| Compensación en Acciones | $269000 | $297000 | $5.4M | $13.9M | $23.8M | $26.3M | $27.1M | $12.6M |
| Cambio en Capital Circulante | -$159000 | $4.3M | $247000 | -$4.0M | $9.8M | $8.3M | -$12.4M | $336000 |
| Flujo de Caja Operativo | -$13.2M | -$14.2M | -$38.3M | -$68.1M | -$89.2M | -$130.4M | -$121.9M | -$84.1M |
| Inversiones (CapEx) | -$653000 | -$353000 | -$31000 | -$4.9M | -$1.4M | -$1.3M | -$447000 | -$212000 |
| Adquisiciones | 0 | 0 | 0 | 0 | $233989 | 0 | 0 | 0 |
| Recompra de Acciones | -$6000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$13.8M | -$14.6M | -$38.3M | -$73.0M | -$90.7M | -$131.6M | -$122.4M | -$84.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$17.1M | -$19.0M | -$18.6M | -$16.1M |
| Inversiones (CapEx) | -$56000 | -$49000 | -$50000 | -$17000 |
| Flujo de Caja Libre | -$17.1M | -$19.0M | -$18.7M | -$16.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.5M | $2.7M | $2.5M | $2.7M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +132.0% | -75.4% | -100.0% | | | | |
| Crecimiento Beneficio Neto (anual) | | -40.1% | -137.7% | -82.5% | -47.9% | -30.2% | +16.1% | +24.6% |
| Crecimiento BPA (anual) | | -11.4% | -45.5% | -61.7% | -46.4% | -23.4% | +31.0% | +26.4% |
| Cambio en Acciones (anual) | | +0.0% | +81.5% | +1.2% | +1.0% | +5.6% | +21.4% | +2.8% |
| Crecimiento FCF (anual) | | -5.5% | -162.4% | -90.6% | -24.1% | -45.2% | +7.0% | +31.1% |
| Margen Bruto | 9.0% | 9.1% | 9.1% | | | | | |
| Margen Operativo | -662.0% | -400.0% | -3694.0% | | | | | |
| Margen EBITDA | -641.3% | -391.1% | -3676.9% | | | | | |
| Margen Neto | -664.3% | -401.2% | -3869.7% | | | | | |
| Margen FCF | -669.7% | -304.5% | -3242.0% | | | | | |
| Tasa Impositiva Efectiva | -0.3% | -0.2% | -0.5% | 0.0% | -0.1% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.63 | $-0.67 | $-0.96 | $-1.81 | $-2.23 | $-3.06 | $-2.35 | $-1.57 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $22.0M | $22.0M | $39.8M | $40.3M | $40.7M | $43.0M | $52.2M | $53.7M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -391.42% |
| Rentabilidad sobre capital invertido | -261.95% |
| Rentabilidad sobre activos | -172.23% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.07 |
| Ratio corriente | 9.71 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -21.32 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -37.97 | -34.09 | -67.34 | -10.38 | -3.72 | -3.98 | -0.65 | -0.59 |
| P/VC | 71.93 | -2386.02 | 7.99 | 2.39 | 1.74 | 3.37 | 0.77 | 2.33 |
| P/V | 318.60 | 137.31 | 2905.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 9.0% | 9.1% | 9.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -662.0% | -400.0% | -3694.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -664.3% | -401.2% | -3869.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |